| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |